Want to join the conversation?
Free cash flow over the last four quarters was at $11.8Bil. $ORCL now has $56Bil in cash & marketable securities. Net of debt, $ORCL cash position is approx. $14Bil. The short term deferred revenue balance is $9.1Bil, up 10% in constant currency. In 1Q16 $ORCL repurchased 75MM shares for a total of $3Bil up from FY15 run rate of $2Bil a quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?